616 related articles for article (PubMed ID: 17376824)
1. Experimental autoimmune encephalomyelitis mediated by CD8+ T cells.
Ji Q; Goverman J
Ann N Y Acad Sci; 2007 Apr; 1103():157-66. PubMed ID: 17376824
[TBL] [Abstract][Full Text] [Related]
2. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
Zozulya AL; Wiendl H
Hum Immunol; 2008 Nov; 69(11):797-804. PubMed ID: 18723060
[TBL] [Abstract][Full Text] [Related]
3. Epicutaneous (EC) immunization with myelin basic protein (MBP) induces TCRalphabeta+ CD4+ CD8+ double positive suppressor cells that protect from experimental autoimmune encephalomyelitis (EAE).
Tutaj M; Szczepanik M
J Autoimmun; 2007 Jun; 28(4):208-15. PubMed ID: 17442539
[TBL] [Abstract][Full Text] [Related]
4. CD8+ T cells in inflammatory demyelinating disease.
Weiss HA; Millward JM; Owens T
J Neuroimmunol; 2007 Nov; 191(1-2):79-85. PubMed ID: 17920696
[TBL] [Abstract][Full Text] [Related]
5. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.
Batoulis H; Addicks K; Kuerten S
Ann Anat; 2010 Aug; 192(4):179-93. PubMed ID: 20692821
[TBL] [Abstract][Full Text] [Related]
6. Endogenous CD4+BV8S2- T cells from TG BV8S2+ donors confer complete protection against spontaneous experimental encephalomyelitis (Sp-EAE) in TCR transgenic, RAG-/- mice.
Matejuk A; Buenafe AC; Dwyer J; Ito A; Silverman M; Zamora A; Subramanian S; Vandenbark AA; Offner H
J Neurosci Res; 2003 Jan; 71(1):89-103. PubMed ID: 12478617
[TBL] [Abstract][Full Text] [Related]
7. The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology?
Johnson AJ; Suidan GL; McDole J; Pirko I
Int Rev Neurobiol; 2007; 79():73-97. PubMed ID: 17531838
[TBL] [Abstract][Full Text] [Related]
8. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting.
Stinissen P; Raus J
Acta Neurol Belg; 1999 Mar; 99(1):65-9. PubMed ID: 10218096
[TBL] [Abstract][Full Text] [Related]
9. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
Yan SS; Wu ZY; Zhang HP; Furtado G; Chen X; Yan SF; Schmidt AM; Brown C; Stern A; LaFaille J; Chess L; Stern DM; Jiang H
Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893
[TBL] [Abstract][Full Text] [Related]
10. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
Holmøy T
Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322
[TBL] [Abstract][Full Text] [Related]
11. Lack of requirement for CD8+ cells in recovery from and resistance to experimental autoimmune encephalomyelitis.
Lohse AW; Schwerdt A; Herkel J; Spahn T; Meyer zum Büschenfelde KH
J Autoimmun; 1995 Jun; 8(3):395-404. PubMed ID: 7576000
[TBL] [Abstract][Full Text] [Related]
12. Recombinant T cell receptor molecules can prevent and reverse experimental autoimmune encephalomyelitis: dose effects and involvement of both CD4 and CD8 T cells.
Kumar V; Coulsell E; Ober B; Hubbard G; Sercarz E; Ward ES
J Immunol; 1997 Nov; 159(10):5150-6. PubMed ID: 9366445
[TBL] [Abstract][Full Text] [Related]
13. [Activation of T cells in experimental autoimmune encephalomyelitis and multiple sclerosis].
Rodríguez-Rodríguez Y; Suárez-Luis I
Rev Neurol; 2003 Apr 1-15; 36(7):649-52. PubMed ID: 12666047
[TBL] [Abstract][Full Text] [Related]
14. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?
Friese MA; Fugger L
Brain; 2005 Aug; 128(Pt 8):1747-63. PubMed ID: 15975943
[TBL] [Abstract][Full Text] [Related]
15. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
Vogt J; Paul F; Aktas O; Müller-Wielsch K; Dörr J; Dörr S; Bharathi BS; Glumm R; Schmitz C; Steinbusch H; Raine CS; Tsokos M; Nitsch R; Zipp F
Ann Neurol; 2009 Sep; 66(3):310-22. PubMed ID: 19798635
[TBL] [Abstract][Full Text] [Related]
16. Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies.
Montero E; Nussbaum G; Kaye JF; Perez R; Lage A; Ben-Nun A; Cohen IR
J Autoimmun; 2004 Aug; 23(1):1-7. PubMed ID: 15236747
[TBL] [Abstract][Full Text] [Related]
17. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
El Behi M; Dubucquoi S; Lefranc D; Zéphir H; De Seze J; Vermersch P; Prin L
Immunol Lett; 2005 Jan; 96(1):11-26. PubMed ID: 15585303
[TBL] [Abstract][Full Text] [Related]
18. Epicutaneously induced TGF-beta-dependent tolerance inhibits experimental autoimmune encephalomyelitis.
Szczepanik M; Tutaj M; Bryniarski K; Dittel BN
J Neuroimmunol; 2005 Jul; 164(1-2):105-14. PubMed ID: 15899524
[TBL] [Abstract][Full Text] [Related]
19. Initiation and regulation of CNS autoimmunity.
Goverman J; Brabb T; Paez A; Harrington C; von Dassow P
Crit Rev Immunol; 1997; 17(5-6):469-80. PubMed ID: 9419434
[TBL] [Abstract][Full Text] [Related]
20. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE).
Ziemssen T; Ziemssen F
Autoimmun Rev; 2005 Sep; 4(7):460-7. PubMed ID: 16137612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
